Addex Therapeutics Ltd
OTC: ADDXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Timothy Mark Dyer
- Employees
- 26
- Headquarters
- Geneva, Switzerland
- IPO year
- 2010
- Website
- https://www.addextherapeutics.com
Loading ADDXF…
Loading profile data…Frequently asked questions about ADDXF
What does Addex Therapeutics Ltd (ADDXF) do?
Addex Therapeutics Ltd is a Swiss-based biopharmaceutical company focused on the discovery, advancement, and commercialization of small-molecule drug candidates for disorders impacting the central nervous system (CNS). The firm's core scientific endeavor is the development of oral, small-molecule allosteric modulators that interact with G-protei...
Where does ADDXF trade?
Addex Therapeutics Ltd (ADDXF) trades on the Other OTC.
What sector is ADDXF in?
Addex Therapeutics Ltd (ADDXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Addex Therapeutics Ltd?
Timothy Mark Dyer is the chief executive officer of Addex Therapeutics Ltd (ADDXF).
Where is Addex Therapeutics Ltd headquartered?
Addex Therapeutics Ltd is headquartered in Switzerland.
Does ADDXF pay a dividend?
Addex Therapeutics Ltd (ADDXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADDXF go public?
Addex Therapeutics Ltd (ADDXF) completed its initial public offering in 2010.